Simultaneous determination of stavudine and lamivudine in human plasma by high performance liquid chromatography and its application to a bioavailability study

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 2, 2010, Pages 369-377

  Wattananat, Triporn ^a   Prasanchaimontri, Ing Orn ^a   Akarawut, Wiyada ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Bioavailability; HPLC UV method; Lamivudine; Stavudine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; STAVUDINE; ZIDOVUDINE;

BIOAVAILABILITY; BLOOD; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PROCEDURES; STANDARD;

ANTI-HIV AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; LAMIVUDINE; REFERENCE STANDARDS; STAVUDINE; ZIDOVUDINE;

EID: 77956054715     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Aymard G, Legrand M, Trichereau N, Diquet B. Determination of twelve antiretroviral agents in human plasma using reversedphase high-performance liquid chromatography. J Chromatogr B 2000;21:227-40.
2. Estrela RC, Salvadori MC, Suarez-Kurtz G. A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection. Rapid Commun Mass Spectrom 2004;18:1147-55.
3. Gurtman A, Borrego F, Klotman ME. Management of antiretroviral therapy. Semin Nephrol 1998;18:459-80.
4. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450-4.
5. Hosseinipour MC, Corbett AH, Kanyama C, et al. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults. AIDS 2007;21:59-64.
6. Jung BH, Rezk NL, Bridges AS, Corbett AH, Kashuba AD. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2007;21:1095-104.
7. Marier JF, DiMarco M, Guilbaud R, et al. Pharmacokinetic of lamivudine, zidovudine, and nevirapine administered as a fixeddose combination formulation versus coadministration of the individual products. J Clin Pharmacol 2007;47:1381-89.
8. Mudigonda K, Jukanti R, Apte SS, et al. Rapid and simple liquid chromatography tandem mass spectrometry method for the quantification of zidovudine in rat plasma. Biomed Chromatogr 2008;22:20-7.
9. Narang VS, Lulla A, Malhotra G, Purandare S. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects. J Clin Pharmacol 2005;45:265-74.
10. Notari S, Bocedi A, Ippolito G, et al. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography. J Chromatogr B 2006;831:258-66.
11. Palella, Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
12. Pereira AS, Kenney KB, Cohen MS, et al. Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry. J Chromatogr B 2000;742:173-83.
13. Rezk NL, Tidwell RR, Kashuba ADM. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. J Chromatogr B 2003;79:137-47.
14. Santos-Magalhaes NS, Pontes A, Cavalcante RM, et al. Bioequivalence of two lamivudine tablet formulations. Arzneimittelforschung 2001;51:310-4.
15. Tarinas A, Tápanes RD, Ferrer G, Pérez J. Validation of high-performance liquid chromatography methods for determination of zidovudine, stavudine, lamivudine and indinavir in human plasma. Farm Hosp 2007;31:243-7.
16. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine: Guidance for Industry-Bioanalytical Method Validation. Washington DC: US Department Health and Human Service, 2001.
17. Verweij-van Wissen CP, Aarnoutse RE, Burger DM. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine, and abacavir in human plasma by reversed phase high performance liquid chromatography. J Chromatogr B 2005;816:121-9.
18. Vezina HE, Henry K, Ravindran GD, et al. A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India. J Acquir Immune Defic Syndr 2006;41:131-6.